Fuchs, S.Y., Adler, V., Pincus, M.R. and Ronai, Z. MEKK1/JNK signaling stabilizes and activates p53. Proc NatlAcad Sci USA 1998b; 95: 10541-10546.
Gao, C. and Tsuchida, N. Activation of caspases in p53-induced transactivation-independent apoptosis. Jpn J Cancer Res 1999; 90: 180-187.
Gerritsen, M.E., Williams, A.J., Ncish, A.S., Moore, S., Shi, Y. and Collins, T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 1997; 94: 2927-2932.
Ghosh, G., van Duyne, G., Ghosh, S. and Sigler, P.B. Structure of NF-kappa B p50 homodimer bound to a kappa B site. Naturę 1995; 373: 303-310.
Ghosh, S., May, M.J. and Kopp, E.B. NF-kappa B and Rei proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260.
Giaccia, A.J. and Kastan, M.B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998; 12: 2973-2983.
Gilmore, T.D. The Rel/NF-kappaB signal transduction pathway: introduction. Oncogene 1999; 18: 6842-6844.
Giri, D.K. and Aggarwal, B.B. Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T celi lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J Biol Chem 1998; 273: 14008-14014.
Giri, 1. and Yaniv, M. Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. Embo J 1988a; 7: 2823-2829.
Giri, I. and Yaniv, M. Study of the E2 gene product of the cottontail rabbit papillomavirus reveals a common mechanism of transactivation among papillomaviruses. J Virol 1988b; 62: 1573-1581.
Goldstein, D.J., Andresson, T,, Sparkowski, J.J. and Schlegel, R. The BPV-1 E5 protein, the 16 kDa membranę pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. Embo J 1992; 11: 4851-4859.
Goodhead, D.T. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. lut JRadiat Biol 1994; 65: 7-17.
Gottlieb, E., Haffncr, R., King, A., Asher, G., Gruss, P., Lonai, P. and Oren, M.
Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis. Embo J 1997; 16: 1381-1390.
Gottlieb, E. and Oren, M. p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53. Embo J 1998; 17: 3587-3596.
Goulian, M., Bleile, B.M., Dickey, L.M., Grafstrom, R.H., Ingraham, H.A., Neynaber, S.A., Peterson, M.S. and Tseng, B.Y. Mechanism of thymineless death. Adv Exp Med Biol 1986; 195 Pt B: 89-95.
Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878.
Grem, J.L. (1990). Fluorinated Pyrimidines. In Cancer chemolherapy: Principles and Practice, Chabner, B.A. & Collins, J.M. (eds) pp. 189-190. Lippincott, J.B.: Philadelphia.
Grossman, S.R. and Laimins, L.A. E6 protein of human papillomavirus type 18 binds zinc. Oncogene 1989; 4: 1089-1093.
171